Insights & News in Healthcare Safety

Fostering the "Value" of the Value Analysis Process in Healthcare

Value analysis is essential for ensuring that healthcare organizations make decisions that enhance patient care while optimizing resources and managing costs effectively. It's about more than just ...

AI in Healthcare Applications and the Potential for Preventable Harm

The advent of artificial intelligence (AI) in healthcare promises transformative changes that could significantly improve clinical outcomes, reduce operational costs, and enhance the quality of car...

ECRI's Top 10 Health Technology Hazards: A Vital Resource for Healthcare Providers

We're excited to announce that ECRI's highly anticipated annual report—Top 10 Health Technology Hazards for 2025—is on the way and is launching early! This report is crucial for healthcare organiza...

Balancing Disinfection and Manufacturer Recommendations in Ultrasound Technologies

Introduction As the use of ultrasound technology continues to expand across various medical disciplines—from radiology and cardiology to point-of-care applications—ensuring appropriate and effectiv...

Five Key Takeaways on Video-Based Patient Monitoring for Preventing Falls

ECRI named ongoing challenges related to patient falls as one of its 2024 Top 10 Patient Safety Concerns because falls continue to be the number one sentinel event reported to the Joint Commission ...

Navigating the Evolving Landscape in Healthcare Value Analysis: Strategies for Success

The role of Value Analysis in Healthcare is pivotal as the industry faces constant change and transformation. Due to the nature of this complex specialty, it is necessary to illustrate and define a...

Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight loss—Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—could potentially make much needed g...

Monitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know

Roughly one year after their introduction, Wegovy (semaglutide) and Zepbound (tirzepatide) continue to shake up the obesity treatment landscape in the United States. Uptake for these two glucagon-l...

Weighing the Evidence on New Weight Loss Drugs – Five Takeaways

The prevalence of overweight and obesity keeps worsening in America despite our enormous collective effort to lose weight. The U.S. Centers for Disease Control and Prevention estimates that overwei...